NANITE INC.
Polymer-based nanoparticle delivery vehicles for mRNA therapeutics, optimized via computational modeling and high-throughput synthesis
- Sector
- Biotech
- Headquarters
- Watertown, MA
- Founded
- 2020
- Latest Form D
- $4.1M, May 2022
- Total capital
- $4.4M
- Federal grants
- $300K
- 1 award · 2023
- Rank in peer group#3 of 20
- Private capital raised
- $4.1M
- 1 Form D · last May 2022
- 54 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Computationally-Inspired Design of Non-Viral Gene Delivery Vehicles for mRNA-Based Cystic Fibrosis Therapies$300K
- Private capital raisedForm D · SEC · 1st filing$4.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 20 peers
Line = medianBiotech · Material
- Federal grants#3 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Sean KevlahanDirector, Executive Officer, PromoterNamed in SEC Form D filings
- Shashi MurthyExecutive OfficerNamed in SEC Form D filings
- Thomas NeenanExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingPolyester Polymers For Biological Agent DeliveryUSPTOApplication PCTUS2025056218
- PendingIn Vivo Expression Of A Polymer Polynucleotide ComplexUSPTOApplication PCTUS2025056220
- PendingIn Vivo Expression Of A Polymer Polynucleotide ComplexUSPTOApplication 63882176
Show all 8 patent records
- Polyester Polymers For Biological Agent DeliveryApplication PCTUS2025056218Pending
- In Vivo Expression Of A Polymer Polynucleotide ComplexApplication PCTUS2025056220Pending
- In Vivo Expression Of A Polymer Polynucleotide ComplexApplication 63882176Pending
- Polyester Polymers For Biological Agent DeliveryApplication 63882171Pending
- Polyester Polymers For Biological Agent DeliveryApplication PCTUS2025018127Pending
- Polymeric System For Biological Agent DeliveryApplication PCTUS2024056696Pending
- Polyester Polymers For Biological Agent DeliveryApplication 63565743Pending
- Polymeric System For Biological Agent DeliveryApplication 63600916Pending
Related companies, and why
- PURE GREEN PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- KANO THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- METERA PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- FANNIN PARTNERS LLCSimilar federal contract value in Biotech · null in contracts
- Compass TherapeuticsSimilar federal contract value in Biotech · null in contracts
- STINGRAY THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .